These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34850597)

  • 41. Impact of atrial fibrillation in heart failure with normal ejection fraction: a clinical and echocardiographic study.
    Fung JW; Sanderson JE; Yip GW; Zhang Q; Yu CM
    J Card Fail; 2007 Oct; 13(8):649-55. PubMed ID: 17923357
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased comorbidities in heart failure patients ≥ 85 years but declined from >90 years: data from the Swedish Heart Failure Registry.
    Holmström A; Sigurjonsdottir R; Edner M; Jonsson A; Dahlström U; Fu ML
    Int J Cardiol; 2013 Sep; 167(6):2747-52. PubMed ID: 22805544
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Left atrial structure and function and the risk of death or heart failure in atrial fibrillation.
    Inciardi RM; Giugliano RP; Claggett B; Gupta DK; Chandra A; Ruff CT; Antman EM; Mercuri MF; Grosso MA; Braunwald E; Solomon SD;
    Eur J Heart Fail; 2019 Dec; 21(12):1571-1579. PubMed ID: 31777160
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of different strategies for identifying asymptomatic left ventricular dysfunction and pre-clinical (stage B) heart failure in the elderly. Results from 'PREDICTOR', a population based-study in central Italy.
    Mureddu GF; Tarantini L; Agabiti N; Faggiano P; Masson S; Latini R; Cesaroni G; Miceli M; Forastiere F; Scardovi AB; Uguccioni M; Boccanelli A
    Eur J Heart Fail; 2013 Oct; 15(10):1102-12. PubMed ID: 23787717
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [C-reactive protein and its associations with сardiometabolic risk factors and echocardiographic indicators of heart failure: results of "Know your heart" study in Arkhangelsk].
    Mirolyubova OA; Kudryavtsev AV; Semchyugova EO; Malyutina SK; Ryabikov AN
    Kardiologiia; 2020 Oct; 60(9):68-75. PubMed ID: 33131477
    [TBL] [Abstract][Full Text] [Related]  

  • 46. N-terminal B-type natriuretic peptide and the association with left ventricular diastolic function in a population at high risk of incident heart failure: results of the SCReening Evaluationof the Evolution of New-Heart Failure Study (SCREEN-HF).
    McGrady M; Reid CM; Shiel L; Wolfe R; Boffa U; Liew D; Campbell DJ; Prior D; Krum H
    Eur J Heart Fail; 2013 May; 15(5):573-80. PubMed ID: 23338855
    [TBL] [Abstract][Full Text] [Related]  

  • 47. NT-proB natriuretic peptide, risk factors and asymptomatic left ventricular dysfunction: results of the SCReening Evaluation of the Evolution of New Heart Failure study (SCREEN-HF).
    McGrady M; Reid CM; Shiel L; Wolfe R; Boffa U; Liew D; Campbell DJ; Prior D; Stewart S; Krum H
    Int J Cardiol; 2013 Oct; 169(2):133-8. PubMed ID: 24080362
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Opportunistic screening models for high-risk men and women to detect diastolic dysfunction and heart failure with preserved ejection fraction in the community.
    Gohar A; Kievit RF; Valstar GB; Hoes AW; Van Riet EE; van Mourik Y; Bertens LC; Boonman-Winter LJ; Bots ML; Den Ruijter HM; Rutten FH
    Eur J Prev Cardiol; 2019 Apr; 26(6):613-623. PubMed ID: 30482050
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The frequency of systolic versus diastolic heart failure in an Egyptian cohort.
    Ibrahim BS
    Eur J Heart Fail; 2003 Jan; 5(1):41-5. PubMed ID: 12559214
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
    Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
    Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease: Insights From PARADIGM-HF.
    Ehteshami-Afshar S; Mooney L; Dewan P; Desai AS; Lang NN; Lefkowitz MP; Petrie MC; Rizkala AR; Rouleau JL; Solomon SD; Swedberg K; Shi VC; Zile MR; Packer M; McMurray JJV; Jhund PS; Hawkins NM
    J Am Heart Assoc; 2021 Feb; 10(4):e019238. PubMed ID: 33522249
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association between cardiovascular vs. non-cardiovascular co-morbidities and outcomes in heart failure with preserved ejection fraction.
    Lund LH; Donal E; Oger E; Hage C; Persson H; Haugen-Löfman I; Ennezat PV; Sportouch-Dukhan C; Drouet E; Daubert JC; Linde C;
    Eur J Heart Fail; 2014 Sep; 16(9):992-1001. PubMed ID: 25046483
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Left Atrial Dysfunction as an Independent Correlate of Heart Failure Symptoms in Patients With Severe Aortic Stenosis and Preserved Left Ventricular Ejection Fraction.
    Mateescu AD; Călin A; Beladan CC; Roşca M; Enache R; Băicuş C; Botezatu S; Ginghină C; Popescu BA
    J Am Soc Echocardiogr; 2019 Feb; 32(2):257-266. PubMed ID: 30717861
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Arterial stiffness and elevated left ventricular filling pressure in patients at risk for the development or a previous diagnosis of HF-A subgroup analysis from the DIAST-CHF study.
    Lüers C; Trippel TD; Seeländer S; Wachter R; Hasenfuss G; Lindhorst R; Bobenko A; Nolte K; Pieske B; Edelmann F
    J Am Soc Hypertens; 2017 May; 11(5):303-313. PubMed ID: 28411073
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of the frontal QRS-T angle with adverse cardiac remodeling, impaired left and right ventricular function, and worse outcomes in heart failure with preserved ejection fraction.
    Selvaraj S; Ilkhanoff L; Burke MA; Freed BH; Lang RM; Martinez EE; Shah SJ
    J Am Soc Echocardiogr; 2014 Jan; 27(1):74-82.e2. PubMed ID: 24075945
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sex differences in factors associated with heart failure and diastolic left ventricular dysfunction: a cross-sectional population-based study.
    Cesaroni G; Mureddu GF; Agabiti N; Mayer F; Stafoggia M; Forastiere F; Latini R; Masson S; Davoli M; Boccanelli A;
    BMC Public Health; 2021 Feb; 21(1):415. PubMed ID: 33639910
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Body composition and echocardiographic abnormalities associated to anemia and volume overload in heart failure patients.
    Colín-Ramírez E; Castillo-Martínez L; Orea-Tejeda A; Asensio Lafuente E; Torres Villanueva F; Rebollar González V; Narváez David R; Dorantes García J
    Clin Nutr; 2006 Oct; 25(5):746-57. PubMed ID: 16698139
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Trajectories of Left Ventricular Ejection Fraction After Acute Decompensation for Systolic Heart Failure: Concomitant Echocardiographic and Systemic Changes, Predictors, and Impact on Clinical Outcomes.
    Albert J; Lezius S; Störk S; Morbach C; Güder G; Frantz S; Wegscheider K; Ertl G; Angermann CE
    J Am Heart Assoc; 2021 Feb; 10(3):e017822. PubMed ID: 33496189
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of Systolic Blood Pressure on Heart Failure Symptoms With Moderate Aortic Stenosis.
    Maeda M; Omori T; Kagawa S; Uno G; Rader F; Siegel RJ; Shiota T
    Am J Cardiol; 2021 Sep; 155():96-102. PubMed ID: 34315571
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inflammatory Biomarkers Predict Heart Failure Severity and Prognosis in Patients With Heart Failure With Preserved Ejection Fraction: A Holistic Proteomic Approach.
    Hage C; Michaëlsson E; Linde C; Donal E; Daubert JC; Gan LM; Lund LH
    Circ Cardiovasc Genet; 2017 Feb; 10(1):. PubMed ID: 28100627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.